Retractable Technologies
RVP
#10092
Rank
A$37.5 M
Marketcap
A$1.25
Share price
1.13%
Change (1 day)
22.71%
Change (1 year)
Categories

Earnings for Retractable Technologies (RVP)

Earnings in 2025 (TTM): -A$9.73 Million

According to Retractable Technologies's latest financial reports the company's current earnings are A$37.9 Million. In 2024 the company made an earning of -A$5.12 Million, an increase over its 2023 earnings that were of -A$13.19 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Retractable Technologies from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$9.73 Million90.1%
2024 -A$5.12 Million-61.23%
2023 -A$13.19 Million-264.33%
2022 A$8.02 M-92.91%
2021 A$0.11 B183.02%
2020 A$39.97 M699.35%
2019 A$5 M-382.55%
2018 -A$1.77 Million-68.32%
2017 -A$5.59 Million6.68%
2016 -A$5.24 Million-176.63%
2015 A$6.83 M-313.87%
2014 -A$3.2 Million-63.96%
2013 -A$8.87 Million51.4%
2012 -A$5.86 Million-332.66%
2011 A$2.51 M-33.82%
2010 A$3.8 M-119.09%
2009 -A$19.93 Million
2007 -A$14.97 Million48.12%
2006 -A$10.11 Million133.42%
2005 -A$4.33 Million
2003 -A$8.89 Million8.78%
2002 -A$8.17 Million-19.17%
2001 -A$10.11 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ICU Medical
ICUI
A$0.18 B-2,165.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
A$2.83 B-31,145.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-A$0.31 Billion 3,280.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Insulet
PODD
A$0.54 B-6,099.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
A$99.14 M-1,186.78%๐Ÿ‡บ๐Ÿ‡ธ USA